Long-term Follow-up Study to Evaluate the Safety and Explore the Efficacy of Multiple Doses of FURESTEM-AD Inj

Safety and Efficacy of FURESTEM-AD Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis (AD)

NCT01927705 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Safety of ADSTEM Injection in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

NCT03252340 ·Status: COMPLETED

A Study to Assess the Efficacy and Safety of MSTT1041A in Participants With Moderate to Severe Atopic Dermatitis

NCT03747575 ·Status: COMPLETED ·Phase: PHASE2

Evaluate Efficacy and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis

NCT06397911 ·Status: RECRUITING ·Phase: PHASE2

Safety and Efficacy in Patients With Moderate to Severe Subacute and Chronic Atopic Dermatitis

NCT04137562 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2

Long-Term Study (AtDvance) to Evaluate GSK1070806 in Atopic Dermatitis.

NCT06447506 ·Status: TERMINATED ·Phase: PHASE2

Long-Term Safety Follow-Up Study of SCM-AGH in Subjects Who Participated and Administered SCM-AGH in to Severe Atopic Dermatitis Clinical Trials

NCT04185584 ·Status: UNKNOWN

Safety Study Evaluating the Adrenal Suppression Potential of Product 0405 in Pediatric Subjects With Atopic Dermatitis

NCT01232543 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Study of QLS12010 Capsules in Adults With Moderate to Severe Atopic Dermatitis

NCT07344051 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2

An Open-Labeled Exploratory Study to Evaluate Safety and Efficacy of FB825 in Adults With Atopic Dermatitis

NCT03758716 ·Status: COMPLETED ·Phase: PHASE2

A Phase II Trial of the Safety and Efficacy of RSS0309 Ointment in Adults With Atopic Dermatitis

NCT07158151 ·Status: COMPLETED ·Phase: PHASE2

A Study to Investigate the Efficacy and Safety of SHR-1905 in Patients With Moderate-to-severe Atopic Dermatitis

NCT07211542 ·Status: RECRUITING ·Phase: PHASE2

Efficacy and Safety Trial of ALK-depot SQ Mites in Subjects With Atopic Dermatitis

NCT00310492 ·Status: COMPLETED ·Phase: PHASE3

Continued Safety Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis Previously Enrolled in the FB401-01 Study

NCT04936113 ·Status: TERMINATED ·Phase: PHASE2

KM110329 in Adult Patients With Atopic Dermatitis

NCT01692093 ·Status: UNKNOWN ·Phase: PHASE2

Evaluate Efficacy of FB825 in Adults With Atopic Dermatitis

NCT05059509 ·Status: COMPLETED ·Phase: PHASE2

A Study of SHR-1819 in Patients With Moderate-to-severe Atopic Dermatitis

NCT07321951 ·Status: RECRUITING ·Phase: PHASE2

Evaluation of FB-401 in Children, Adolescents and Adults (2 Years and Older) With Mild to Moderate Atopic Dermatitis

NCT04504279 ·Status: COMPLETED ·Phase: PHASE2

Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects

NCT02176551 ·Status: WITHDRAWN ·Phase: PHASE3

Study to Evaluate the Safety and Efficacy of Alefacept (Amevive) in Subjects With Moderate to Severe Atopic Dermatitis

NCT00832585 ·Status: COMPLETED ·Phase: PHASE4

Efficacy, Safety, and Pharmacokinetic Profiles of REGN3500 Administered to Adult Patients With Moderate-to-Severe Atopic Dermatitis

NCT03738423 ·Status: TERMINATED ·Phase: PHASE2

Safety and Efficacy of ADSTEM Inj. in Patients With Moderately Subacute and Chronic Atopic Dermatitis

NCT02888704 ·Status: COMPLETED ·Phase: PHASE1

Study to Evaluate the Use of RHT-3201 in SCORAD Reduction in Young Patients With Atopic Dermatitis

NCT03907228 ·Status: UNKNOWN ·Phase: NA

A Study to Test the Safety, Pharmacokinetics, and Efficacy of UCB9741 in Healthy Study Participants and in Study Participants With Atopic Dermatitis

NCT04643457 ·Status: COMPLETED ·Phase: PHASE1/PHASE2

Study of the Safety, Tolerability and Efficacy of BTX 1204 in Patients With Moderate Atopic Dermatitis

NCT03824405 ·Status: COMPLETED ·Phase: PHASE2